|
TW200817400A
|
|
Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
TW200815436A
|
|
4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
TW200738677A
|
|
Nitro-substituted hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
|
|
EP1688141A1
|
|
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
|
NZ540085A
|
|
Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
|
|
KR20050026095A
|
|
Method for producing highly pure hydroxy indolyl glyoxylic acid amides
|
|
TW200410690A
|
|
Topical treatment of skin diseases
|
|
DE10318609A1
|
|
5-hydroxyindoles with N-oxide groups and their use as therapeutic agents
|
|
DE10318611A1
|
|
4-, 6- or 7-hydroxyindoles with N-oxide groups and their use as therapeutic agents
|
|
DE10318610A1
|
|
7-azaindoles and their use as therapeutic agents
|
|
DE10253426A1
|
|
Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and methods for their preparation
|
|
DE10241407A1
|
|
Treatment of non-allergic rhinitis with selective phosphodiesterase 4 inhibitors
|
|
TWI262920B
|
|
New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
|
